Core & Main Reports Downbeat Results, Joins Rev Group, PagerDuty, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures dipping over 100 points on Wednesday.
Shares of Core & Main Inc CNM fell sharply in today's pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY24 net sales guidance below estimates.
Core & Main reported quarterly earnings of 61 cents per share which missed the analyst consensus estimate of 73 cents per share. The company reported quarterly sales of $1.964 billion which missed the analyst consensus estimate of $2.059 billion.
Core & Main shares dipped 17.1% to $38.80 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
- Zscaler Inc
ZS shares fell 17.1% to $160.19 in pre-market trading following fourth-quarter earnings.
- Ascendis Pharma A/S
ASND declined 15.2% to $114.17 in pre-market trading after the company reported worse-than-expected second-quarter sales results and cut its FY24 SKYTROFA revenue guidance.
- Asana Inc
ASAN fell 14.6% to $11.36 in pre-market trading. Asana reported upbeat results for its second quarter but issued weak guidance for the third quarter.
- Rev Group Inc
REVG shares fell 13.3% to $26.19 in pre-market trading following weak quarterly sales.
- PagerDuty, Inc.
PD fell 12% to $16.10 in today’s pre-market trading. PagerDuty reported better-than-expected earnings for its second quarter, while sales missed estimates.
- Dollar Tree Inc
DLTR shares dipped 10.8% to $72.78 in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut FY24 outlook.
- America’s Car-Mart, Inc.
CRMT shares fell 9.5% to $54.00 after the company reported a year-over-year decrease in quarterly EPS results.
- Hormel Foods Corp
HRL fell 7.1% to $30.78 in pre-market trading after the company reported mixed third-quarter financial results and cut its FY24 sales guidance with its midpoint below estimates.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.